Zhejiang Wolwo Bio-Pharmaceutical Hits Day Low Amid Price Pressure at CNY 23.28

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 5.76% on March 23, 2026. The stock reached an intraday low of CNY 23.28, reflecting a challenging trading session. Over the past week, the stock has seen a decrease of 5.95%, while its performance over the past month has been more pronounced, with a drop of 13.79%. In comparison, the China Shanghai Composite index fell by 3.63% today and has shown a decline of 6.65% over the past week. Despite the recent downturn, Zhejiang Wolwo has demonstrated resilience over the past year, with a return of 10.5%, although this is below the Shanghai Composite's 13.33% gain. The company maintains a strong market position within the pharmaceuticals and biotechnology sector, boasting a market capitalization of CNY 12,510 million. Key financial metrics include a return on equity of 14.15% and a price-to-earnings ratio of 45.00. The stock's performance continues to be closely monitored as it navigates current market conditions.